We are actively conducting and preparing clinical studies in the following areas:
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Alcohol-Associated Liver Disease (ALD)
Cholestatic Liver Diseases (e.g., PBC, PSC)
Cirrhosis and Complications of Advanced Liver Disease
Obesity and Cardiometabolic Conditions
Specific study availability changes over time. Eligibility depends on individual study criteria.
All information provided is kept confidential and used solely for clinical trial screening and research purposes.
What to expect when taking part in a clinical trial at Evidentis.
Clinical trials follow a protocol-defined process designed to evaluate investigational therapies in a safe and organized manner. While individual studies vary, participants who proceed beyond initial screening can generally expect the steps below.
Healthcare providers may refer eligible patients to Evidentis clinical trials through a secure, HIPAA-compliant process that supports continuity of care and appropriate follow-up.
How to Refer:
Submit the secure referral form with relevant clinical details.
Our team reviews study availability and eligibility criteria.
We will contact the patient directly and provide updates when appropriate and permitted.
Please share patient details for clinical trial referral.